Women in Science: “I felt like a God”- Dr. Katalin Karikó

As many will know, the Nobel Prize for Physiology or Medicine 2023 was awarded jointly to Dr. Katalin Karikó and Dr. Drew Weissman in recognition of their contribution to the mRNA technology that laid the groundwork for the Covid-19 mRNA vaccine success. They found that replacing uridine with pseudouridine in mRNA molecules prevented over-activation of an immune response that would normally degrade and remove the mRNA. Combined with successful delivery to cells, this allowed for mRNA to be used as coding machinery to make new proteins in cells that don’t normally produce that protein. One small adjustment changed the landscape of mRNA technology and therapeutics.

Since the Nobel Prize announcement, it has come to light the many obstacles and rejections that Dr. Karikó adapted to over the course of her career and despite it all, was still awarded the most prestigious title in scientific research. Taking inspiration from this, we will run a new blog series to highlight female scientists, their work and what it is that we admire most about them. (Did you know? Only 13 of the 227 Nobel Prize Laureates for Physiology or Medicine were women!)

In her many interviews and discussions, it is obvious that Dr. Karikó has an exceptional positive mental attitude and, most importantly, lives and breathes for science. The title of this blog post, “I felt like a God”, is a quote from Dr. Karikó. Most people will think that it is a reaction to hearing she won the Nobel Prize. But no, it was Dr. Karikó’s reaction in the 1980s to seeing her mRNA inserted into cells and producing a new protein. Dr. Karikó was still working at the bench up until very recently, and this love for lab work and science is one quality that makes her stand out from the crowd. She shy’s away from the “fame” and focuses on “what’s next”. It is these qualities, I assume that meant she could push past the rejections that we know so well in academia and scientific research. Before her and Dr. Weissman’s work was noticed and valued by Pfizer and Bio-N-Tech, Dr. Karikó was let go from the University of Pennsylvania due to a lack of grant funding and struggled to attract interest from both industry and academia. In fact, major journals rejected Dr. Karikó and Dr. Weissman’s work on mRNA modifications, and it was finally published in a lesser-known journal, Immunity.

Rejections are something that every scientist becomes accustomed to, be they grant rejections, job rejections or even “idea” rejections. Dr. Karikó’s ability to firmly believe in her science and never let up is what I admire most about her. She was told so many times to “not bother” with RNA that it would never be used as a therapeutic. And now, her belief and self-confessed obsession with this molecule has contributed to the development of arguably the most ground-breaking therapeutic of the 21st century, the mRNA vaccine. Obviously, as an immunologist, I am biased. But it cannot be ignored how many lives Dr. Karikó’s ambition and determination have benefited.

Dr. Katalin Karikó working at her new desk as a newly-appointed Professor at her alma mater, the University of Szeged, Hungary. Picture courtesy of Dr Kariko’s Twitter account @kkariko.

As women in science, we face unique challenges. Dr. Karikó’s career is not what you would expect from a Nobel prize-winning scientist. It is not littered with tenured positions at Ivy League universities. She struggled for most of her career to get people to listen to her about the promise of mRNA. Moving from her home of Hungary to the United States with her husband and young daughter, Susan, who is now a two-time Olympic gold medallist. When asked how she juggled it all, Dr. Karikó explains how leading by example is the key. It is no wonder her daughter is as successful as she is when Dr. Karikó’s determination, perseverance and self-confidence were what she grew up watching. I truly admire Dr. Karikó’s ability to stand firm in the face of adversity. For me, she stands as a true role model for women scientists and embodies the success that resilience can bring. 

Written by Ellen King

Knit-A-Thon 2023 Results

A wonderful day of knitting – Knit-A-Thon-2023 raised 913 euros. A massive thank you to everyone who stopped by and donated on the day and beyond. Every cent counts! The money was split evenly between our four chosen charities: The Conor Foley Neuroblastoma Research Foundation (CFNRF)Neuroblastoma UK (NBUK)Oscars Kids and Childhood Cancer Ireland (CCI). These charities were established and are run by parents, some of whom lost their children to cancer. They continue their children’s legacy, doing an amazing job of advocating for children with cancer and better funding for research and aftercare.

Knit-A-Thon 2023

And a special thank you to Ciara’s mam Aggie for the amazing handmade raffle prizes (chromosomes, antibodies, cup holders and many more) and a Master class on the day! We thank Jenny Duffy (RCSI Events and Communications Coordinator) for her time crocheting with us and for us!  Thanks to Anggie’s and Jenny’s skills, there were lots of mascots to win – and many of them collected already. We much appreciate the support from the RCSI Estates and Porters who looked after us on the day.

Go Raibh Maith Agat!!!

MANY THANKS FOR YOUR BIG HEARTS!!!

Knit-A-Thon 2023


We are the Cancer Bioengineering Group, and September is a very special month for us as it is Childhood Cancer Awareness Month. Childhood cancer is the 2nd leading cause of death in children after accidents. Our group researches childhood cancer neuroblastoma, a cancer of immature nerve cells. Despite intensive multimodal treatment, as many as 1 in 5 children with aggressive neuroblastoma do not respond, and up to 50% of children that do respond experience disease recurrence with many metastatic tumours resistant to many drugs and more aggressive tumour behaviour that all too frequently results in death.

This is what we want to change! We believe that every child deserves a future, and our team of postgraduate researchers led by Dr Olga Piskareva is dedicated to strengthening our knowledge of this disease and identifying new potential ways to tackle it, as well as taking part in fundraising activities so our group and others can continue with this research.  

On Tuesday, the 19th of September, we are running a Knit-A-Thon using gold and purple yarn to mark childhood cancer and neuroblastoma, respectively. Our patterns are inspired by Neuroblastoma UK and Mr Google, indeed.

This year, we honour 4 charities that are doing an amazing job of advocating for children with cancer and better funding for research and aftercare. Therefore, the donations we receive will be split equally among The Conor Foley Neuroblastoma Research Foundation (CFNRF), Neuroblastoma UK (NBUK), Oscars Kids and Childhood Cancer Ireland (CCI). If you would like to get involved in the Knit-A-Thon and help us raise vital funds for childhood cancers, come along on the day and make a donation to these wonderful charities.

On the day, RCSI 123 SSG will #GoGold in support of this cause. Please come by to see the RCSI building lit up and share your pictures on social media with the hashtag #ChildhoodCancerAwarenessMonth to raise awareness.

Ready, Steady, Go!

Every year we manage to raise an amazing 1500-2000 euros by organising a new challenge. We are eager to surpass that target this year. All donations no matter how small are appreciated at GoFundMe.

Growing cancer cells in 3D

Hi there, Ciara here again, a final-year PhD student in our research group. I can’t believe September has rolled around again, meaning one thing: it’s Childhood Cancer Awareness Month (CCAM). In honour of this month, I would like to tell you a little bit about the childhood cancer we study in our lab and the research that I do to one day help save children from this disease. 

Neuroblastoma is an aggressive childhood cancer, with sadly only 20% of late-stage patients surviving after 5 years. Progressive disease and cancer relapse are common in neuroblastoma. This is due to standard treatment regimens not being adequate for treating high-risk patients. Current treatment also may cause a series of adverse reactions in patients. Therefore, my research focuses on developing a 3D model of high-risk neuroblastoma that models the cancer more accurately in a laboratory setting. This will act as a beneficial platform to test whether new therapies effectively fight the patients’ cancer cells, leading to better treatment options for children with neuroblastoma.  

Below is a picture of how we grow these cancerous cells on our 3D model and visualise them with fluorescent stains. When we can see them like this under a microscope, we can study how they move and grow to help us understand how to treat them. 

Here, we can see the cells growing on our 3D cancer model. This image is magnified by 200 times to be able to see the individual cancer cells. The green stain is the outside of our cancer cells, or we use the term, the cell membrane. The blue is the inside, or as some of you may know the term, the nucleus of the cell.   (It is amazing what we can see with the power of microscopes, right?) 

As you may know, every year, we support amazing charities by raising vital funds to keep the fight against childhood cancer going. Keep your eyes peeled on our Twitter for updates on what crazy activity we have committed to this year!!  

Written by Ciara Gallagher

Childhood Cancer Awareness Month 2023

Every September, we celebrate Childhood Cancer Awareness Month. This is a great opportunity to raise awareness about childhood cancer. Unfortunately, kids get cancer, too. While much research has been done to understand how cancer develops in adults, we still know very little about what exactly leads to cancer in children.

We are the Cancer BioEngineering Group led by Dr Olga Piskareva at the RCSI University of Medicine and Health Sciences. Our research focuses on neuroblastoma, an aggressive childhood cancer of immature nerves. The group has 7 PhD students developing research projects around neuroblastoma biology. One postgraduate student successfully defended her work and was awarded a PhD last month.

We are a dynamic group proud to be engaged in research, science communication and patient involvement. We do that through different initiatives. Throughout September, we will share many of them and invite you to keep following us on social media. 

Team 2023

Our projects address topics related to neuroblastoma microenvironment, cell interactions, tumour resistance and the development of new therapies. To do that, we use 3D in vitro models, identify immunotherapeutic targets and evaluate extracellular vesicles.  

We are always happy to answer questions and interact with the public. Follow us on our social media channels and read our blog to learn more about us and our research.  

We are running a fundraising event, “A knit-a-thon,” on the 19th of September. Stay tuned!

Thanks for reading, and we go ahead with neuroblastoma research! 

Experiencing Elegance: A Graduation Ceremony at the University of Siena, Italy

This blog takes you to the exciting scene of my MSc graduation ceremony at the University of Siena, Italy, completed with the prestigious laurel wreath.

I graduated during COVID-19, but there was no graduation ceremony at that time. Years later, I was invited to attend an “Alumni conference” by the University of Siena, but the plan was still unclear. When we arrived in Siena, we came across that there was a convocation ceremony tomorrow. Hold on! What? Yes, after years of waiting, it was finally taking place on June 7, 2023.

The next morning, all the former students from 48 countries came together in the University’s Grand Piazza del Duomo, where all of the Professors and sponsors, robed in their academic attire, delivered speeches that inspired and reminded us of the responsibility that comes with education, which ended in the most captivating moment of adorning us with laurel wreaths stating that “Rating your thesis attributes by authority granted to me by director I confer you the Masters Diploma in Vaccinology and Drug Development, Congratulations!”. The weight of this academic success was alleviated by our family members’ joyful yells and applause.

Walking out of the ceremony, wreathed in laurel, walking through Siena’s streets with classmates I’ve never met in person, hearing these words “Complimenti! Felicitazioni!” from commoners, I came back to Dublin with an ethereal sensation of pride and belonging that will remain with me for life. Altogether, It was a once-in-a-lifetime experience for me.

Here are some glimpses of the ceremony:

P.S.: But this was not the end. I embarked on a wet-lab MSc in RCSI Dublin. As I am typing these lines, my MSc by Research work has just been submitted for examination, marking another hallmark and opening a new chapter in my life, “the PhD journey”. The new chapter – the new challenges and opportunities!

Written by Rabia Saleem

Dine With Rabia

As our festive season is around the corner, I decided to look at the delicious cuisine that all Asians must-have on this special occasion. “I’d like to share one of the most well-known South Asian classic recipes, Biryani,” which is especially famous in Pakistan. We enjoy it at weddings and festivals. It is a must-have dish when we invite guests to our place.

The aroma of biryani in abroad always reminds me of special times and joy in Pakistan. The nicest part about biryani is sharing it with family and friends. My grandmother passed down the family recipe for biryani to my mother, and I’m fortunate that I learned to make it from her.

Ingredients:

Cooked by Rabia
  • 1/2 kg of lamb or chicken
  • 1 cup of cooking oil
  • 1 tbs. Warmed spices
  • 4 Fried Onions
  • 1 tbsp. ginger-garlic paste
  • 2 Tomatoes
  • 1/2 cup of yoghurt
  • 1 tsp. Lemon juice
  • 4-6 Green chillies
  • 1 tbsp. red chilli powder
  • 1 Teaspoon Salt
  • Pinch saffron
  • 1/2 kg of Basmati rice

Recipe:

  1. Take a stainless-steel pot, add a half cup of oil, and heat it over medium heat. Add the onions and cook for 10–15 minutes. Add the ginger-garlic paste and cook it until everything turns golden brown. It almost seems like it’s going to burn, but this is okay.
  2. Add lamb or chicken along with all other ingredients except saffron, lemon, and rice. Cook uncovered, stirring constantly, until the tomatoes are soft. Lower the heat to low. Add a half cup of water. Mix it well and simmer it until the meat becomes soft and tender. And this will be your
  3. Meanwhile, boil the rice in another large pot and bring 4 quarts of water to a boil with 2 tablespoons of salt. Add washed basmati rice to boiling water. Boil it for 4 minutes, and then Drain it in a colander.
  4. Mix lemon juice and saffron.
  5. Gently Layer the basmati rice on top of the khurma. Sprinkle the saffron-lemon mixture over the rice. Cover the pot tightly and simmer it for 12–15 minutes or until the rice is tender. When it’s finished, give it a couple good stirs to spread the meat and spices. It does not have to be perfectly even.
  6. Serve with yoghurt chutney or just on its own.
  7. Enjoy!

Written by Rabia Saleem

Summer Research: A Journey of Insight with the Cancer Bioengineering Group

Eight weeks ago, my journey into the intricate world of neuroblastoma began as I embarked on a remarkable research experience with the Cancer Bioengineering Group at RCSI. Guided by Dr. Olga Piskareva and supported by RCSI Research Summer School, this experience would transform my perspective on scientific exploration forever.

On my first day in the lab, excitement and nervousness mingled within me. But as I stepped into the bustling lab space, I was greeted with warm smiles and a sense of camaraderie among the researchers. The Cancer Bioengineering Group was known for its collaborative spirit, and it didn’t take long for me to feel like a valued member of the team.

RSS 2023 in Action

The research work was a perfect blend of diversity and fascination, encompassing both desk assignments and hands-on lab experiments. The highlight of it all was the chance to work with the cutting-edge 3D bio-printing machine, Rastrum. Witnessing the process of 3D bio-printing and using it to seed the Kelly cell line in various matrices left me in awe of the potential this technology held for future cancer therapies.

Yet, this journey extended beyond the realm of research. It was about the people – the passionate researchers who inspired and supported one another, the dedicated support staff who kept the lab running smoothly, and most notably, Dr. Olga Piskareva and Alysia Scott. They were more than mentors; they became friends and confidants, guiding me through challenges with unwavering support and celebrating our achievements as a team.

As the eight weeks drew to a close, I couldn’t help but reflect on the immense growth I had experienced professionally and personally. The cancer bioengineering field has unveiled the possibilities of using engineering principles to combat a disease that has touched countless lives worldwide.

This journey instilled in me a profound sense of purpose – a drive to contribute to the fight against neuroblastoma and other devastating illnesses. With a heart full of gratitude, I bid farewell to the Cancer Bioengineering Group at RCSI, knowing that the friendships forged and the knowledge gained would forever shape my future endeavours in the world of cancer research.

In the end, it wasn’t merely an eight-week stint; it was a transformational odyssey that solidified my passion for scientific discovery and my determination to make a difference in the lives of those affected by cancer. And for that, I will be eternally grateful.

Written by Mohammad Alabdulrahman, MED Class of 2026

Many Heys from New York!

Everyone, many heys from New York! I just started my pediatric residency at SUNY Downstate, Brooklyn, and I love this place! The weather is bright and shiny – I always admire it, passing by hospital windows. I live in a wonderful place; it takes just 5 minutes to get to the clinic. New York is a grand city with so many things to do – I would definitely go out on one of these weekends. Oh, wait, I’m working 24h and then catching up on my lost sleep. Well, there is always another time… if I get enough energy to muster after work.

Really, it is a lot of work, coming to a new country and starting residency, but I enjoy it. I had the best possible start – I interned in the Nursery, overseeing the treatment of neonates in their first three days of lives. And taking care of the newborns is what sold Pediatrics to me in the first place. I also love continuity of care, meaning that I will follow the same children for the next 3 years, observing their health and helping them grow. And I can attest to how wonderful the feeling is when you see an infant you knew from his first hours of life thriving and developing.

Dr. Nadiya

I like being an intern but can’t wait for the second year when I will have a pediatric oncology rotation at Memorial Sloan Kettering Cancer Center, a leading world cancer for pediatric oncology treatment. Furthermore, it has teams working on treating patients with neuroblastoma and is where research and clinical trial take place. I aim to join one of the projects and continue the work that I started with Dr Olga Piskareva. She taught me to love research and inspired me to improve my skills and reach new highs. I miss my time working with Dr Piskareva and the neuroblastoma lab, both research and social parts, and I hope to see them all soon – at one of the neuroblastoma conferences. 🙂

Written by Nadiya Bayeva

A newly minted Dr. Catherine Murphy

Huge congrats to a newly minted Dr Catherine Murphy! ✨ She successfully defended her PhD work yesterday. Hard work and dedication paid off. Well done, Catherine!

We thank examiners Drs Oran Kennedy and Niamh Buckley for their time and expertise provided.

We also thank Neuroblastoma UK for their generous support!